|
|||||
|
|
Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC |
|
| Authors: | Jianmin Wang Pu Zhou Xudong Wang Yongxin Yu Guangkuo Zhu Linpeng Zheng Zihan Xu Feng Li Qiai You Qiao Yang Wenlei Zhuo Jianguo Sun Zhengtang Chen |
| Abstract: | |
| Keywords: | EGFR‐TKI resistance NSCLC Rab25 β 1 integrin β ‐catenin |